Tag: Arv

While antiretroviral (ARV) therapy has dramatically transformed HIV from a fatal diagnosis into a manageable chronic condition, with mortality rates decreasing significantly, it is not without its drawbacks. Understanding what are the disadvantages of taking ARV is crucial for managing treatment effectively and maintaining long-term health.

Antiretroviral therapy (ART) has dramatically changed HIV from a fatal diagnosis to a manageable chronic condition, largely due to the development of **ARV**, or antiretroviral drugs. These medications are the backbone of modern HIV treatment and prevention strategies, giving the immune system a chance to recover by controlling viral replication.

Advancements in HIV treatment have led to a variety of oral medications, but many patients wonder which ARV is blue, often referring to specific, recognizable tablets. The answer most commonly points to Truvada and Descovy, two key antiretroviral drugs used for both HIV treatment and prevention.

Over 90% of people who take antiretroviral therapy (ART) as prescribed achieve an undetectable viral load within 12 months, allowing their immune system to recover and live long, healthy lives. It is a persistent and dangerous myth that ARV drugs weaken the immune system, but the opposite is true. This article will separate fact from fiction and explain the critical role of ARVs in restoring and preserving immune function in people living with HIV.

According to the South African Health Products Regulatory Authority (SAHPRA), Ranega belongs to a group of medicines known as antiretrovirals (ARVs) and is used to treat HIV-1 infection. The answer to the question, "**Is Ranega an arv?**" is yes, as it is a single tablet containing three powerful active substances designed to combat the virus effectively.